Oncology Reviews

, Volume 4, Issue 4, pp 233-267

First online:

Screening of high-risk groups for breast and ovarian cancer in Europe: a focus on the Jewish population

  • Karen L. BelkićAffiliated withInstitute of Oncology-Pathology, Karolinska Institute and HospitalSchool of Community and Global Health, Claremont Graduate UniversityInstitute for Prevention Research, The Keck School of Medicine of the University of Southern California Email author 
  • , Miri CohenAffiliated withDepartment of Gerontology, Faculty of Social Welfare and Health Sciences, University of Haifa
  • , Marcela MárquezAffiliated withInstitute of Oncology-Pathology, Karolinska Institute and HospitalSchool of Medicine, Autonomous University of Nuevo Leon
  • , Miriam MintsAffiliated withDepartment of Obstetrics and Gynecology, Karolinska Institute and Hospital
  • , Brigitte WilczekAffiliated withDepartment of Mammography, Unilabs AB, Sankt Gorans Hospital
  • , Anne H. BermanAffiliated withDepartment of Clinical Neurosciences, Karolinska Institute and Hospital
  • , Enrique CastellanosAffiliated withDepartment of Oncology-Pathology, Karolinska Institute and Hospital
  • , Martha CastellanosAffiliated withStockholm Ambulatory Care Center

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Low breast cancer screening rates are often found among ethnic minority groups and those born outside the host country. This is of particular concern for high-risk groups, who should benefit from ongoing trials aimed at optimizing screening strategies for breast, as well as ovarian cancer. Both of these issues are germane for Jewish women in Europe. We systematically review the literature concerning breast cancer early detection practices (BCEDP) among Jewish women, and examine European surveillance studies of high-risk for breast and/or ovarian cancer that had imaging in the surveillance protocol, in order to assess the likelihood of adequately including women from minority ethnic groups. No studies were found about BCEDP among Jewish women in Europe. Twenty-one research groups from Israel or the US addressed BCEDP among Jewish women. Some Jewish women in the US and Israel, including recent immigrants, are under-screened. Twenty-four research groups reported imaging surveillance of women at increased risk for breast and/or ovarian cancer in Europe. There was a clear benefit to magnetic resonance imaging and/or more intensive screening for women with increased breast cancer risk. Some of these surveillance studies considered ethnic minority groups at high risk, including Jewish women, but none provided adequate outreach to ensure that these groups were included in their programs. The specific screening needs of Jewish and other high-risk ethnic minority groups in Europe have not been met regarding breast and ovarian cancer. A European-wide, population-based approach is suggested, with cultural sensitivity being vital for these efforts.


Breast cancer Ovarian cancer Early detection Imaging surveillance BRCA mutations Cultural sensitivity